InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Scanlon Meghan, Vice-Présidente Senior, Présidente Urologie Santé Pelvique et Administratrice. Officer active across 2 companies, notably Boston Scientific CORP. In total, 13 disclosures have been recorded. History available since 1 May 2021. The latest transaction was disclosed on 17 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Scanlon Meghan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
42,113 股Common StockSEC:0000950170-25-056369:0
15,906 股0Common StockSEC:0001610717-24-000251:0
8,361 股0Common StockSEC:0001610717-23-000056:0
2,062 股0Common StockSEC:0001225208-22-006331:0
17,846 股0Common StockSEC:0001567619-22-008111:0
1,019 股0Common StockSEC:0001225208-22-003868:0
779 股0Common StockSEC:0001225208-22-003088:0
1,583 股0Common StockSEC:0001225208-22-002933:0
1,108 股0Common StockSEC:0001225208-22-002699:0
13,850 股@ US$23.4153.5% 占其流量Common StockSEC:0001225208-21-010901:0
855 股0Common StockSEC:0001225208-21-010279:0
16,450 股@ US$17.2646.5% 占其流量Common StockSEC:0001225208-21-009606:0
2,061 股0Common StockSEC:0001225208-21-007475:0
13 条申报中的 13 条
About Scanlon Meghan
Meghan Scanlon is an executive at BOSTON SCIENTIFIC CORP.
